150 related articles for article (PubMed ID: 9605744)
1. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots.
Chen JX; Zheng Y; West M; Tang MS
Cancer Res; 1998 May; 58(10):2070-5. PubMed ID: 9605744
[TBL] [Abstract][Full Text] [Related]
2. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
Hu W; Feng Z; Tang MS
Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
[TBL] [Abstract][Full Text] [Related]
3. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
4. 5-Methylcytosine in CpG sites and the reactivity of nearest neighboring guanines toward the carcinogen aflatoxin B1-8,9-epoxide.
Ross MK; Mathison BH; Said B; Shank RC
Biochem Biophys Res Commun; 1999 Jan; 254(1):114-9. PubMed ID: 9920742
[TBL] [Abstract][Full Text] [Related]
5. Endogenous cytosine methylation and the formation of carcinogen carcinogen-DNA adducts.
Tretyakova N; Guza R; Matter B
Nucleic Acids Symp Ser (Oxf); 2008; (52):49-50. PubMed ID: 18776247
[TBL] [Abstract][Full Text] [Related]
6. Formation of diastereomeric benzo[a]pyrene diol epoxide-guanine adducts in p53 gene-derived DNA sequences.
Matter B; Wang G; Jones R; Tretyakova N
Chem Res Toxicol; 2004 Jun; 17(6):731-41. PubMed ID: 15206894
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
Puisieux A; Lim S; Groopman J; Ozturk M
Cancer Res; 1991 Nov; 51(22):6185-9. PubMed ID: 1933877
[TBL] [Abstract][Full Text] [Related]
8. Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene.
Tang MS; Zheng JB; Denissenko MF; Pfeifer GP; Zheng Y
Carcinogenesis; 1999 Jun; 20(6):1085-9. PubMed ID: 10357792
[TBL] [Abstract][Full Text] [Related]
9. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
Tornaletti S; Pfeifer GP
Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
[TBL] [Abstract][Full Text] [Related]
10. The influence of cytosine methylation on the chemoselectivity of benzo[a]pyrene diol epoxide-oligonucleotide adducts determined using nanoLC/MS/MS.
Glick J; Xiong W; Lin Y; Noronha AM; Wilds CJ; Vouros P
J Mass Spectrom; 2009 Aug; 44(8):1241-8. PubMed ID: 19536795
[TBL] [Abstract][Full Text] [Related]
11. N-hydroxy-4-aminobiphenyl-DNA binding in human p53 gene: sequence preference and the effect of C5 cytosine methylation.
Feng Z; Hu W; Rom WN; Beland FA; Tang MS
Biochemistry; 2002 May; 41(20):6414-21. PubMed ID: 12009904
[TBL] [Abstract][Full Text] [Related]
12. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
[TBL] [Abstract][Full Text] [Related]
13. Methylation and repeats in silent and nonsense mutations of p53.
Kouidou S; Malousi A; Maglaveras N
Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
[TBL] [Abstract][Full Text] [Related]
14. Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis.
You YH; Pfeifer GP
J Mol Biol; 2001 Jan; 305(3):389-99. PubMed ID: 11152598
[TBL] [Abstract][Full Text] [Related]
15. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic potential of benzo[a]pyrene-derived DNA adducts positioned in codon 273 of the human P53 gene.
Dong H; Bonala RR; Suzuki N; Johnson F; Grollman AP; Shibutani S
Biochemistry; 2004 Dec; 43(50):15922-8. PubMed ID: 15595848
[TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-methylcytosine in sunlight-induced mutagenesis.
You YH; Li C; Pfeifer GP
J Mol Biol; 1999 Oct; 293(3):493-503. PubMed ID: 10543945
[TBL] [Abstract][Full Text] [Related]
18. Cytosine methylation in a CpG sequence leads to enhanced reactivity with Benzo[a]pyrene diol epoxide that correlates with a conformational change.
Weisenberger DJ; Romano LJ
J Biol Chem; 1999 Aug; 274(34):23948-55. PubMed ID: 10446162
[TBL] [Abstract][Full Text] [Related]
19. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
[TBL] [Abstract][Full Text] [Related]
20. DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene.
Choi JH; Pfeifer GP
Mutat Res; 2004 Dec; 568(2):245-56. PubMed ID: 15542111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
